BrainStorm: a multicenter international study to tackle CNS metastases in solid tumors
Diogo Martins-Branco(Université Libre de Bruxelles), Nuria Kotecki(Centre Oscar Lambret), Anthony Gonçalvès(Centre National de la Recherche Scientifique), Hannelore Denys(Ghent University Hospital), Ahmad Awada(Centre Hospitalier Interrégional Edith Cavell), Claire Cheymol(Centre Oscar Lambret), Nadège Kindt(University of Mons), Philippe Barthélémy(Centre National de la Recherche Scientifique), François P. Duhoux(Cliniques Universitaires Saint-Luc), Guilherme Nader Marta(Université Libre de Bruxelles), Eleonora De Maio D’Esposito(Institut Claudius Regaud), Lore Decoster(Universitair Ziekenhuis Brussel), Marianne Paesmans(Université Libre de Bruxelles), Florian Clatot, Vincent Vanhaudenarde(CHU Dinant Godinne UCL Namur), Joseph Gligorov(Sorbonne Université), Stéphane Holbrechts(CHU Ambroise Paré), Édith Borcoman(Institut Curie), Andrea Gombos(Institut Jules Bordet), Jean-Luc Canon, Paul M. Clément(Universitair Ziekenhuis Leuven), Florence Lefranc(Université Libre de Bruxelles), Caroline Duhem(Centre Hospitalier de Luxembourg)
Cited by 2
Related Papers
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
|Annals of Oncology|2021|1.4k
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
|Annals of Oncology|2020|1.4k
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
|New England Journal of Medicine|2019|1.3k
Lomustine and Bevacizumab in Progressive Glioblastoma
|New England Journal of Medicine|2017|994
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients
|British Journal of Cancer|2007|957